Pooled efficacy, patient-reported outcomes, and safety of roflumilast cream 0.15% from the INTEGUMENT-1 and INTEGUMENT-2 phase 3 trials of adults and children with atopic dermatitis

被引：0
|
作者：
Simpson, Eric [1 ]
Boguniewicz, Mark [2 ,3 ]
Eichenfield, Lawrence [4 ]
Gonzales, Mercedes E. [5 ]
Hebert, Adelaide A. [6 ]
Prajapati, Vimal H. [7 ,8 ]
Gooderham, Melinda [9 ,10 ]
Krupa, David [11 ]
Chu, David H. [11 ]
Higham, Robert C. [11 ]
Berk, David R. [11 ]
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR USA
[2] Natl Jewish Hlth, Denver, CO USA
[3] Univ Colorado, Sch Med, Aurora, CO USA
[4] Univ Calif San Diego, Radys Childrens Hosp San Diego, San Diego, CA USA
[5] Pediat Skin Res LLC, Miami, FL USA
[6] UT Hlth, McGovern Med Sch, Houston, TX USA
[7] Skin Hlth Wellness Ctr, Dermatol Res Inst & Prob Med Res, Calgary, AB, Canada
[8] Univ Calgary, Calgary, AB, Canada
[9] SKiN Ctr Dermatol, Prob Med Res, Peterborough, ON, Canada
[10] Queens Univ, Peterborough, ON, Canada
[11] Arcutis Biotherapeut Inc, Westlake Village, CA USA
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2024年 / 191卷
关键词：
atopic dermatitis; efficacy; patient-reported outcomes; roflumilast cream; safety;
D O I：
10.1093/bjd/ljae266.022
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
641
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Tralokinumab Efficacy Over 1 Year in Adults with Moderate-to-Severe Atopic Dermatitis: Pooled Data from Two Phase III Trials
    Simpson, Eric L.
    Pink, Andrew E.
    Blauvelt, Andrew
    Gooderham, Melinda
    Armstrong, April W.
    Worm, Margitta
    Katoh, Norito
    Peris, Ketty
    Puig, Luis
    Barbarot, Sebastien
    Mark, Thomas
    Steffensen, Louise Abildgaard
    Tindberg, Ann-Marie
    Wollenberg, Andreas
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2023, 24 (06) : 939 - 952
  • [32] Tralokinumab Efficacy Over 1 Year in Adults with Moderate-to-Severe Atopic Dermatitis: Pooled Data from Two Phase III Trials
    Eric L. Simpson
    Andrew E. Pink
    Andrew Blauvelt
    Melinda Gooderham
    April W. Armstrong
    Margitta Worm
    Norito Katoh
    Ketty Peris
    Luis Puig
    Sébastien Barbarot
    Thomas Mark
    Louise Abildgaard Steffensen
    Ann-Marie Tindberg
    Andreas Wollenberg
    American Journal of Clinical Dermatology, 2023, 24 : 939 - 952
  • [33] Patient-reported outcomes with abrocitinib treatment in patients with moderate to severe atopic dermatitis: Results from a randomized, phase 3 clinical trial
    Silverberg, Jonathan I.
    Cohen, Arnon D.
    Stander, Sonja
    Feeney, Claire
    Valdez, Hernan
    Biswas, Pinaki
    Cameron, Michael C.
    DiBonaventura, Marco
    Gerber, Robert A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB35 - AB35
  • [34] Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema: pooled results of the phase 3 DELTA-1 and-2 trials
    Bissonnette, Robert
    Worm, Margitta
    Warren, Richard B.
    Agner, Tove
    Gooderham, Melinda
    Schuttelaar, Marie Louise
    Baranowski, Keith
    Plohberger, Ursula
    Soerensen, Laura
    Schliemann, Sibylle
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
  • [35] Achieving a deep response on patient-reported outcomes with upadacitinib in patients with moderate-to-severe atopic dermatitis: results from three phase III trials
    Chovatiya, R.
    Schuttelaar, M. -L.
    Calimlim, B.
    Liu, Y.
    Takemoto, S.
    Staender, S.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E161 - E161
  • [36] Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: Results from 2 phase 3, randomized, double-blind studies
    Papp, Kim
    Szepietowski, Jacek C.
    Kircik, Leon
    Toth, Darryl
    Eichenfield, Lawrence F.
    Leung, Donald Y. M.
    Forman, Seth B.
    Venturanza, May E.
    Sun, Kang
    Kuligowski, Michael E.
    Simpson, Eric L.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (04) : 863 - 872
  • [37] Efficacy and safety of dupilumab monotherapy in adults with moderate-to-severe atopic dermatitis: a pooled analysis of two phase 3 randomized trials (LIBERTY AD SOLO 1 and LIBERTY AD SOLO 2)
    Thaci, Diamant
    Simpson, Eric L.
    Deleuran, Mette
    Kataoka, Yoko
    Chen, Zhen
    Gadkari, Abhijit
    Eckert, Laurent
    Akinlade, Bolanle
    Graham, Neil M. H.
    Pirozzi, Gianluca
    Ardeleanu, Marius
    JOURNAL OF DERMATOLOGICAL SCIENCE, 2019, 94 (02) : 266 - 275
  • [38] Effect of Tofacitinib on Efficacy and Patient-Reported Outcomes in Psoriasis Patients with Baseline Psoriatic Arthritis: A Pooled Analysis of 2 Phase 3 Studies
    Bachelez, Herve
    Griffiths, Christopher E. M.
    Papp, Kim
    Hall, Stephen
    Merola, Joseph F.
    Feldman, Steven R.
    Khraishi, Majed
    Tallman, Anna
    Tan, Huaming
    Hsu, Ming-Ann
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [39] Efficacy, Safety, and Long-Term Disease Control of Ruxolitinib Cream Among Adolescents with Atopic Dermatitis: Pooled Results from Two Randomized Phase 3 Studies
    Eichenfield, Lawrence F.
    Simpson, Eric L.
    Papp, Kim
    Szepietowski, Jacek C.
    Blauvelt, Andrew
    Kircik, Leon
    Silverberg, Jonathan I.
    Siegfried, Elaine C.
    Kuligowski, Michael E.
    Venturanza, May E.
    Kallender, Howard
    Ren, Haobo
    Paller, Amy S.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2024, 25 (04) : 669 - 683
  • [40] Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2
    Cork, Michael J.
    Eckert, Laurent
    Simpson, Eric L.
    Armstrong, April
    Barbarot, Sebastien
    Puig, Luis
    Girolomoni, Giampiero
    de Bruin-Weller, Marjolein
    Wollenberg, Andreas
    Kataoka, Yoko
    Remitz, Anita
    Beissert, Stefan
    Mastey, Vera
    Ardeleanu, Marius
    Chen, Zhen
    Gadkari, Abhijit
    Chao, Jingdong
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2020, 31 (06) : 606 - 614
12345